In the recent few years, increasing evidences indicates that ETK is overexpressed in various cancer types, including prostate cancer, bladder cancer, nasopharyngeal carcinoma, lung cancer and breast cancer[18,22-25]. This evidence concerns the gene BMX and cancer.